Government Taps Radiological Waste to Strengthen U.S. Access to New Cancer-fighting Therapies: The scalable, cost-effective model helps secure a domestic supply of scarce medical radioisotope feedstocks while reducing legacy radiological waste.
An experimental drug developed by GSK functionally cured 19% of patients with hepatitis B in two Phase 3 trials published in The New England Journal of Medicine. The drug, bepirovirsen, targets HBV messenger RNA to block viral protein production, promote destruction of the virus, and stimulate immune responses. The company has submitted the data to Regulators in the United States, Europe, Canada, Japan, and China.
The US Food and Drug Administration (FDA) has finalized a revised draft guidance from 2022 on what Human Factors (HF) information Sponsors should include in Premarket submissions for medical devices.
The first panic attack Quinn Pulsipher remembers having was at 8 years old. They describe it as “a pitch-black ghost that hugs them all over and tries to control their mind.” At the beach on vacation with their family, the wind suddenly picked up, and Quinn began hyperventilating, screaming, and crying uncontrollably. Nothing could calm them down.
“Beauty is pain,” goes a famous maxim. Physiologically, there is some truth to it; studies have shown that chronic pain does last longer and feel stronger for women than men, despite such claims often being dismissed. New research published in Feruary 2026 in Science Immunology might finally suggest why.
Mouse research points to new infertility treatment using approved drug: Research with mice showed that the FDA-approved drug finerenone can stimulate early follicle growth, leading to more mature eggs and increased fertility. In a small, uncontrolled study with people who have primary ovarian insufficiency, treatment with finerenone was followed by the production of mature eggs and fertilized embryos, suggesting a possible new option for patients who typically cannot benefit from standard IVF.